Literature DB >> 6272254

Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung.

G Engel.   

Abstract

Binding studies have been performed in guinea pig and human lung membranes with the radioligand ICYP and several 'cardioselective' beta-adrenoceptor antagonists. Analysis of data from displacement curves by means of a curve fitting procedure, based on a non-linear regression analysis, indicated that in both tissues beta 1- and beta 2-type adrenoceptors coexisted. The relative proportions of the two receptor subtypes in a single tissue remained constant, irrespective of the antagonist used. The percentage of distribution between beta 1- and beta 2-adrenoceptors was about 22:78 in the guinea pig lung and 30:70 in human lung. For the compounds investigated, the affinities of beta 1- and beta 2-adrenoceptors correlated highly significantly between both species, suggesting that the 'cardioselectivity ratio" of a compound is the same in the guinea pig and in man. Mathematical treatment of the displacement curves provided no evidence of a further class of beta-adrenoceptors in lungs of both species.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272254

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

Review 1.  Adrenoceptors and the lung: their role in health and disease.

Authors:  D Reinhardt
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

Review 2.  Airway receptors.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 3.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

4.  Affinity spectra: a novel way for the evaluation of equilibrium binding experiments.

Authors:  H J Tobler; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

5.  Subtype-selective up-regulation of human saphenous vein beta 2-adrenoceptors by chronic beta-adrenoceptor antagonist treatment.

Authors:  O E Brodde; H R Zerkowski; N Doetsch; M Khamssi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

6.  Mammalian platelet adrenoceptors.

Authors:  R Kerry; M C Scrutton; R B Wallis
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

7.  Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.

Authors:  S H Jackson; D G Beevers
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

8.  Characterisation of the beta adrenergic response cascade in fetal guinea pig lung.

Authors:  M E Lyon; C A Lefebvre; D J Davis
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

9.  Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

Authors:  S B Liggett; J C Marker; S D Shah; C L Roper; P E Cryer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.

Authors:  Akhil Hegde; Ryan T Strachan; Julia K L Walker
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.